Close Menu

NEW YORK (GenomeWeb) — The Association for Molecular Pathology (AMP) today updated its official position on direct-to-consumer genomic testing for healthcare decision making, offering an expanded list of conditions that tests must meet before gaining the organization's support.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.